Lion's Mane (Hericium erinaceus)

Mainstream "smart mushroom" with a real but highly fraction-dependent mechanism: erinacines (mycelium) cross the BBB and stimulate NGF in vitro; hericenones (fruiting body) mostly don't. The marketing is much louder than the human evidence — the strongest RCT (Mori 2009) was small, Japanese, MCI population, and the benefit regressed at washout. For Dylan: cheap, safe, plausible upside as a daily-core background neurotrophic, but lower priority than the Russian peptide layer he already has planned for actual NGF/BDNF lift. Verdict: OPTIONAL-ADD. If used, pick a product that explicitly labels % erinacine A or at minimum a dual fruiting-body+mycelium extract — the 70%+ of the Lion's Mane market that's grain-padded mycelium powder is essentially β-glucan-light immune support, not a nootropic.

Lion's Mane is unusual in that it has two anatomically distinct active fractions, and most retail products contain mainly the wrong one for the brain claim.

1. Hericenones (fruiting body) — weak BBB crossing. The fruiting body (the visible above-ground mushroom) contains hericenones C–H, aromatic compounds that stimulate NGF synthesis in cultured astrocytes/glial cells. In vitro, hericenones increase NGF mRNA expression at micromolar concentrations. In vivo, BBB penetration is poor — hericenones are large, polar, and poorly absorbed orally. Most fruiting-body extract effect on the brain is therefore probably indirect (via gut-brain signaling, immunomodulation, possibly vagal pathway), not direct NGF stimulation in the brain itself.

2. Erinacines (mycelium, especially erinacine A) — strong BBB crossing. Erinacines A–K are diterpenoid compounds produced by the underground mycelial network. Erinacine A in particular is the most-studied NGF stimulator in this genus, with clear BBB penetration (rat brain tissue concentrations measurable after oral dosing). In vitro it stimulates NGF mRNA expression at lower concentrations than hericenones and produces measurable NGF increases in rat brain tissue after oral feeding. This is the molecule the "Lion's Mane is a nootropic" claim actually rests on — but it's only present in the mycelium, and at meaningful concentrations only in carefully cultured mycelial extracts (Mycology Research Laboratories' "EAMyc" / Hericium erinaceus mycelium enriched with erinacine A is the most-studied prep, used in the Lai 2020 trial below).

3. β-glucans + heteropolysaccharides — immune + GI. Both fruiting body and mycelium contain β-glucans (immunomodulatory, dendritic-cell activating via dectin-1) and complex polysaccharides that are likely responsible for the gut + immune signal. These are responsible for most of the "feels healthy" subjective experience and are the basis of the Lion's Mane → ulcerative colitis / GI-protection literature. They probably also drive the gut-brain → mood/anxiety effect anecdotally reported.

4. Hericystins, hericinines, palmitic acid amides, isohericenone, sterols. Minor components with various claimed effects (anti-inflammatory, gastroprotective, anti-ulcer). Not load-bearing for the cognitive claim.

5. NGF vs. BDNF. The classic claim is "Lion's Mane stimulates NGF" — and that's mostly correct, NGF is the better-replicated finding. BDNF claims are weaker. Some studies show modest BDNF rises in animal models, but in humans the BDNF data is thin and inconsistent. If you want clean BDNF lift, this is not the cleanest tool — Semax/NASA, bromantane (HDAC modulation → BDNF), and exercise itself are stronger choices. NGF specifically supports cholinergic neuron survival + peripheral sensory neurons, which is why the strongest signal is in MCI/Alzheimer-spectrum populations and (anecdotally) peripheral nerve recovery — relevant to Dylan's cubital tunnel thread.

Pharmacokinetics: Poorly characterized in humans. Erinacine A oral bioavailability in rats is ~10-20% based on brain tissue measurements; hericenones probably <5%. Half-life data essentially absent for human serum. Effects build over 2-4 weeks of daily use — the in-vitro NGF stimulation drives downstream neurite outgrowth/synapse remodeling, which is a slow process. Acute single-dose effects are minimal to absent. This is decisively a chronic-use, weeks-to-months intervention, not a "take before exam" tool.